Sign In
Buy SEER
$1.86
-0.0100 (-0.535%)
At Close: Jun 03, 2026
Seer (NASDAQ:SEER) Trading 1.1% Higher – Here’s Why
02:31am, Tuesday, 06'th Jan 2026
Seer, Inc. (NASDAQ: SEER - Get Free Report) shares rose 1.1% during trading on Monday. The stock traded as high as $1.8450 and last traded at $1.84. Approximately 48,443 shares traded hands during mid
Large-scale GWAS across ~1,600 samples shows how peptide-level mass spectrometry distinguishes true protein changes from potential binding artifacts resulting from affinity-based approaches, establish
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
07:00am, Friday, 07'th Nov 2025
Studies spanning cardiovascular, aging, and cancer biology highlight how Seer's Proteograph® platform is enabling discovery at population scale Studies spanning cardiovascular, aging, and cancer biol
Seer, Inc. (SEER) Q3 2025 Earnings Call Transcript
08:16pm, Thursday, 06'th Nov 2025
Seer, Inc. ( SEER ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Kelly Gura Omid Farokhzad - Founder, CEO, & Chair of the Board of Directors David Horn - President,Treasurer
Seer Reports Third Quarter 2025 Financial Results
04:05pm, Thursday, 06'th Nov 2025
REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the third
Seer to Participate in Upcoming November Investor Conferences
04:05pm, Wednesday, 29'th Oct 2025
REDWOOD CITY, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced company management will be par
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
04:05pm, Thursday, 16'th Oct 2025
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
05:01am, Thursday, 16'th Oct 2025
The company aims to uncover molecular and cellular signatures associated with disease onset, progression, and risk, often before clinical symptoms appear.
Scientific presentations reveal how Seer's Proteograph Product Suite is a critical component of multi-omic translational studies and enables profiling of protein isoform-specific biomarkers Scientific
Seer, Inc. (SEER) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
04:42pm, Tuesday, 09'th Sep 2025
Seer, Inc. (NASDAQ:SEER ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 12:20 PM EDT Company Participants Omid Farokhzad - Founder, CEO, & Chair of the Board of Directors C
Seer Appoints Isaac Ro to its Board of Directors
07:00am, Tuesday, 02'nd Sep 2025
REDWOOD CITY, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced it has appointed Isaac Ro to
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
04:05pm, Tuesday, 26'th Aug 2025
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be parti
Seer, Inc. (SEER) Q2 2025 Earnings Call Transcript
03:16am, Thursday, 07'th Aug 2025
Seer, Inc. (NASDAQ:SEER ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants David R. Horn - President,Treasurer & CFO Kelly Gura - Corporate Participant Omid C.
Seer (SEER) Q2 Revenue Jumps 32%
12:37am, Thursday, 07'th Aug 2025
Seer (SEER -2.83%), a life sciences technology firm specializing in advanced proteomics, released its second quarter results for fiscal 2025 on August 6, 2025. Seer reported GAAP revenue of $4.1 milli
Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates
07:46pm, Wednesday, 06'th Aug 2025
Seer, Inc. (SEER) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.35 per share a year ago.
